UFP TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UFP TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	146	148	190	198	179	206	354	400	504	603
Cost of revenue	111	112	142	144	135	155	264	288	358	432
Gross profit	34.7	35.5	48.3	54	44.7	51.1	90.3	112	147	170
Research and development	1.3	5	10.5	8.8	8.2	8.5	9.3	7.2	10.4	8.6
Selling, general and administrative	24.1	23.7	27.7	29.3	27.5	29.5	45.8	50.9	62.2	77.4
Operating income	12.2	11.7	19.6	24.7	16.7	21.2	55.4	57.7	80.9	92.3
Interest expense	0.07	0.05	1.32	0.67	0.08	0.04	2.76	3.65	8.06	9.8
Interest income	0.15	0.22	0.05	0	0	0.05
Other non-operating income	0.08	0.17	0.06	-0.39	-0.37	0.03	0.08	-0.12	0.19	-0.02
Pre-tax income	12.3	11.9	18.4	23.6	16.3	21.2	52.7	53.9	73	82.5
Income tax	4.35	2.65	4.09	3.9	2.91	5.32	10.9	8.98	14	14.2
Net income	7.97	9.21	14.3	19.8	13.4	15.9	41.8	44.9	59	68.3
EBITDA	17.9	17.3	27.4	32.9	25	29.6	67.3	69.1	95.6	111
EPS, basic	1.11	1.27	1.95	2.66	1.79	2.11	5.52	5.89	7.69	8.87
EPS, diluted	1.10	1.26	1.93	2.63	1.77	2.09	5.45	5.83	7.58	8.75
Shares, basic (weighted)	7.19	7.25	7.35	7.42	7.48	7.52	7.56	7.62	7.67	7.71
Shares, diluted (weighted)	7.28	7.34	7.43	7.52	7.57	7.62	7.66	7.7	7.79	7.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	31.4	38	3.24	3.74	24.2	11.1	4.45	5.26	13.5	20.3
Receivables	21.2	21.4	28.3	28.6	26.4	39.4	55.1	64.4	84.7	82.9
Inventory	14.2	12.9	19.6	18.3	18.6	33.4	53.5	70.2	87.5	86.9
Other current assets	2.28	1.84	2.21	2.3	2.56	3.38	3.24	3.43	4.3	5.62
Total current assets	69.8	75.1	55.6	53.3	71.9	87.3	116	145	195	201
Property, plant and equipment	48.5	53.7	57.7	56.7	53.8	56.6	58.1	62.1	70.6	79.1
Lease right-of-use assets			0	3.03	2.05	9.05		13.4	16.1	18.8
Goodwill	7.32	7.32	51.8	51.8	51.8	108	113	113	190	197
Intangible assets	0.32		22.2	21	19.7	67.6	68.4	64.1	144	141
Other non-current assets	0.15	0.14	0.2	0.15	0.15	1.1	3.64	0.47	0.45	3.44
Total assets	128	138	190	189	203	334	378	404	629	655
Accounts payable	4	4.18	6.84	4.58	4.12	10.6	20	22.3	24.3	24.3
Accrued liabilities	4.7	5.47	8.46	8.48	7.94	16.8	23.1	22.1	30.4	28.8
Deferred revenue		0.3	2.51	2.57	1.89	4.25	4.68	6.62	4.67	4.24
Short-term debt	0.86		2.86		0	4	4	4	12.5	12.5
Total current liabilities	9.56	9.94	20.7	16.8	15.1	38.8	56	58.2	76.3	74.9
Long-term debt			22.3		0	71	51	28	177	123
Lease liabilities			0	1.94	0.95	6.9		10.7	12.4	14
Other non-current liabilities	0.18	0.08	0.02	0.33	1.27	15.2	18.2	15.2	11.1	3.53
Total liabilities	14.9	14.5	49.1	26.8	26.3	140	141	118	286	231
Total debt	0.86		25.1		0	75	55	32	189	135
Paid-in capital	25.2	26.7	29.2	31	32.5	34.2	36.1	38.8	40.9	45.9
Retained earnings	88.4	97.6	112	132	145	161	203	248	307	375
Treasury stock	-0.59	-0.59	-0.59	-0.59	-0.59	-0.59	-0.59	-0.59	-0.59	-0.59
Other comprehensive income						0	-0.61	0.27	-4.17	3.71
Shareholders' equity	113	124	140	162	177	194	238	286	343	424
Total equity	113	124	140	162	177	194	238	286	343	424
Total liabilities and equity	128	138	190	189	203	334	378	404	629	655
Shares outstanding	7.21	7.28	7.39	7.45	7.5	7.58	7.64	7.64	7.68	7.68

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	7.97	9.21	14.3	19.8	13.4	15.9	41.8	44.9	59	68.3
Depreciation and amortization	5.63	5.64	7.83	8.17	8.27	8.41	11.9	11.4	14.7	19.2
Stock-based compensation	1.06	1.07	1.21	1.59	1.81	2.43	3.21	4.64	6.84	8.85
Deferred income tax	0.58	-1.02	1.88	0.79	0.14	-1.79	-4.48	0.82	1.28	5.12
Change in receivables	-3.77	-0.13	-2.56	-0.33	2.22	-7.75	-16.9	-9.12	1.22	5.34
Change in inventory	0.05	1.29	-2.3	1.3	-0.37	-4.5	-19.6	-16.6	-4.69	3.9
Change in payables	-0.68	0.09	1.11	-2.47	-0.68	0.1	9.13	1.55	-1.14	-1.09
Cash from operations	9.31	17.5	21.3	31.2	25	14.3	17.7	41.3	66.6	91.9
Capital expenditures	-7.21	-10.4	-5.43	-5.78	-4.37	-5.4	-13.8	-10.5	-9.66
Acquisitions			-77	0	0	-96.2	-20.7	0	-197	-14.7
Cash from investing	-7.19	-10.4	-82.3	-5.77	-4.26	-101	1.29	-10.5	-210	-27.6
Debt issued			20	0	0	40	0	0	125	0
Debt repaid	-1.01	-0.86	-2.86	-17.1	0	0	-4	-4	-35.1	-12.5
Stock issued				0.71	0.47	0.16	0.39	0.68	0.23	0.19
Cash from financing	-0.56	-0.48	26.3	-25	-0.29	74	-25.9	-30	152	-58.2
Net change in cash	1.56	6.62	-34.7	0.51	20.5	-13.1	-6.67	0.81	8.19	6.85
Free cash flow	2.1	7.09	15.9	25.5	20.7	8.9	3.96	30.8	56.9
Interest paid	0.07	0.05	1.3	0.66	0.07	0.05	2.72	3.54	7.89	9.86
Income taxes paid	3.56	3.88	3.46	1.26	2.48	5.91	13.2	10.6	12.8	3.56

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $295.65 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.5%	Gross profit / revenue.
Operating margin	15.3%	Operating income / revenue.
Pre-tax margin	14.0%	Pre-tax income / revenue.
Net margin	11.4%	Net income / revenue.
Operating cash flow margin	11.3%	Cash from operations / revenue.
Effective tax rate	18.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.6%	Net income / average total assets.
Return on invested capital (ROIC)	13.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	13.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	19.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	27.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	16.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	23.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	30.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	14.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	18.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	40.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	16.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	18.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	34.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	15.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	17.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	38.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	15.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	17.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	37.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	38.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	73.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	29.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	23.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	21.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	19.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	20.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	26.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.00x	Current assets / current liabilities.
Quick ratio	1.56x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.12x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.25x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.2%	Total debt / total assets.
Liabilities / assets	32.2%	Total liabilities / total assets.
Net debt	$108.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	12.4x	Operating income / interest expense.
Working capital	$156.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	48.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$130.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.93x	Revenue / average total assets.
Fixed asset turnover	8.21x	Revenue / average property, plant and equipment.
Inventory turnover	4.51x	Cost of revenue / average inventory.
Days inventory	81 days	365 x average inventory / cost of revenue.
Receivables turnover	5.58x	Revenue / average receivables.
Days sales outstanding	65 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	120 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$9.28	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$81.10	Revenue / diluted weighted shares.
Operating cash flow per share	$9.19	Cash from operations / diluted weighted shares.
Book value per share	$59.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.88	Tangible book value / shares outstanding.
Cash per share	$1.17	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.29B	Share price x shares outstanding.
Enterprise value	$2.40B	Market cap + total debt - cash - short-term investments.
P/E	31.7x	Market cap / net income. Only when net income is positive.
P/S	3.63x	Market cap / revenue.
P/B	4.95x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	17.5x	Market cap / tangible book value, when positive.
P/OCF	32.0x	Market cap / cash from operations, when positive.
EV/Sales	3.80x	Enterprise value / revenue.
EV/EBIT	24.9x	Enterprise value / operating income, when both are positive.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
PEG	1.85x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was UFP TECHNOLOGIES INC's revenue in fiscal 2025?

UFP TECHNOLOGIES INC reported revenue of $602.8M for fiscal 2025, 19.5% higher than the year before.

Was UFP TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $68.3M, a net margin of 11.3%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UFP TECHNOLOGIES INC